Aminosalicylic acid
- Generic Name
- Aminosalicylic acid
- Brand Names
- Granupas, Paser D/r, Granupas (previously Para-aminosalicylic acid Lucane)
- Drug Type
- Small Molecule
- Chemical Formula
- C7H7NO3
- CAS Number
- 65-49-6
- Unique Ingredient Identifier
- 5B2658E0N2
- Background
An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid.
- Indication
For the treatment of tuberculosis
- Associated Conditions
- Tuberculosis (TB)
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Conditions
- Pulmonary TuberculosisRifampicin-resistant Tuberculosis
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Beijing Chest Hospital
- Target Recruit Count
- 186
- Registration Number
- NCT06081361
- Locations
- 🇨🇳
Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China
🇨🇳People's Hospital of Linyi, Linyi, China
🇨🇳Fourth People's Hospital of Nanning, Nanning, China
High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
- Conditions
- Crohn's Disease
- Interventions
- Drug: PASER placebo granules
- First Posted Date
- 2007-01-04
- Last Posted Date
- 2008-10-15
- Lead Sponsor
- Jacobus Pharmaceutical
- Target Recruit Count
- 54
- Registration Number
- NCT00417690
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
🇺🇸Charlotte Gastroenterology and Hepatology, PLLC, Charlotte, North Carolina, United States
🇮🇱Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
- Conditions
- HIV InfectionsTuberculosis
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 525
- Registration Number
- NCT00000796
- Locations
- 🇺🇸
Montefiore Drug Treatment Ctr / Bronx Municipal Hosp, Bronx, New York, United States
🇺🇸Cook County Hosp, Chicago, Illinois, United States
🇺🇸Bronx Lebanon Hosp Ctr, Bronx, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.